ESTA
Establishment Labs Holdings
NASDAQ · Health Care
$68.79
+2.43 (+3.66%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 171.31M | 156.55M | 541.96M | 539.28M | 472.33M |
| Net Income | -87,286,927 | -71,788,571 | 78.36M | 84.21M | 79.25M |
| EPS | — | — | — | — | — |
| Profit Margin | -51.0% | -48.4% | 14.5% | 15.6% | 16.8% |
| Rev Growth | +9.4% | +9.4% | +2.6% | +20.3% | +23.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 804.83M | 804.83M | 1.05B | 803.63M | 1.04B |
| Total Equity | 194.62M | 194.62M | 1.39B | 1.58B | 1.62B |
| D/E Ratio | 4.14 | 4.14 | 0.76 | 0.51 | 0.64 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -51,220,302 | -44,466,130 | 139.34M | 154.42M | 134.93M |
| Free Cash Flow | — | — | 104.04M | 89.33M | 60.76M |